Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment.

Liying ZhouQing LiJingshen XuShuaikang WangZhiqiang SongXinyi ChenYan MaZhiguang LinBobin ChenHe Huang

Published in: Neuro-oncology advances (2022)

We developed a logical regression model based on metabolic markers in CSF that can effectively predict PCNSL patient prognosis before the HD-MTX-based chemotherapy treatments.

Keyphrases

cerebrospinal fluid
high dose
low dose
stem cell transplantation
diffuse large b cell lymphoma
case report
locally advanced
squamous cell carcinoma
combination therapy
radiation therapy